Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma, Kaposi × Filgrastim × Clear all

Sponsor

Conditions

Lymphoma 50 Multiple Myeloma 47 Leukemia 39 Leukemia, Myeloid, Acute 38 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Lymphoma, Non-Hodgkin 34 Myelodysplastic Syndromes 31 Hodgkin Disease 31 Lymphoma, Large B-Cell, Diffuse 26 Lymphoma, Mantle-Cell 25 Leukemia, Lymphocytic, Chronic, B-Cell 23 Lymphoma, Follicular 22 Breast Neoplasms 20 Burkitt Lymphoma 18 Lymphoma, B-Cell, Marginal Zone 16 Lymphoma, Large-Cell, Immunoblastic 14 Congenital Abnormalities 14 Recurrence 12 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11 Sarcoma 10 Neoplasms, Plasma Cell 10 Leukemia, Myelomonocytic, Juvenile 9 Leukemia, Biphenotypic, Acute 9 Leukemia, Myelomonocytic, Chronic 8 Hematologic Neoplasms 8 Blast Crisis 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Neuroblastoma 7 Myeloproliferative Disorders 7 Leukemia, Myeloid, Accelerated Phase 7

Interventions

Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 Valganciclovir 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 tocilizumab 1 pomalidomide 1 pembrolizumab 1 liposomal doxorubicin 1 emvododstat 1 efineptakin alfa 1 Zidovudine 1 Sunitinib 1 Polymerase Chain Reaction 1 Nivolumab 1 Nelfinavir 1 Maraviroc 1 Lenalidomide 1 Ipilimumab 1 Immunohistochemistry 1 HhAntag691 1 Gene Expression Profiling 1 Etoposide 1 Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 CTLA-4 Antigen 1 Antiretroviral Therapy, Highly Active 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡